Fredrik Dahl is a serial life science entrepreneur with a proven track record of transforming early ideas to commercial products in the diagnostics and life science research fields. He was CTO and co-founder of Vanadis Diagnostics, which was acquired by PerkinElmer in December 2015, and CTO and co-founder of Halo Genomics, acquired by Agilent Technologies in 2011. Fredrik's experience also includes research and management positions at US-based start-up companies Ion Torrent Systems and Complete Genomics. He conducted postdoctoral studies at Stanford University and holds a Ph.D. in Molecular Medicine from Uppsala University.
BioTech, Life Sciences, Diagnostics
📍 Ansässig in Stockholm
Direktes E-Mail-Muster
KI Outreach Agenten Pitch Writer
Erstelle personalisierte Anschreiben basierend auf den genauen Investitionskriterien...